Related Experiment Video
Updated: Jun 28, 2026

05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
Amnestic MCI future clinical status prediction using baseline MRI features
Simon Duchesne1, Christian Bocti, Kathy De Sousa
1Radiology Department, Université Laval, Québec, Canada. duchesne@ieee.org
Neurobiology of Aging
|October 25, 2008
Summary
An automated method using MRI scans can predict Alzheimer's disease progression in individuals with mild cognitive impairment. This technique achieved 81% accuracy, offering a valuable tool for early detection and patient management.
Area of Science:
- Neuroimaging
- Neurology
- Biomedical Engineering
Background:
- Amnestic mild cognitive impairment (aMCI) is a precursor to Alzheimer's disease (AD).
- Predicting progression from aMCI to AD is crucial for timely intervention.
- Current prediction methods may lack objectivity or require longitudinal data.
Purpose of the Study:
- To evaluate an automated classification technique for predicting future AD diagnosis in aMCI patients.
- To assess the accuracy of structural MRI scans for retrospective clinical status prediction.
- To determine the utility of single time-point MRI data in forecasting AD progression.
Main Methods:
- Utilized structural magnetic resonance imaging (MRI) from 31 aMCI subjects.
- Employed a leave-one-out classification within a multidimensional MRI feature space.
- Feature space derived from intensity and local volume estimates from AD and control subjects.
Main Results:
- The automated MRI classification achieved 81% accuracy in predicting future clinical status.
- Sensitivity was 70%, and specificity reached 100% for predicting progression to probable AD.
- Progression to AD occurred within an average of 2.2 years for 20 subjects.
Conclusions:
- Automated, single time-point structural MRI analysis is a viable method for predicting AD progression in aMCI.
- The technique demonstrates high accuracy and specificity, offering an objective tool.
- This approach holds potential for aiding clinical decision-making and patient management in aMCI.
